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INTRODUCTION
Thiopurines have a long history of clinical usage as immunosuppressants and in cancer chemotherapy. Combination therapy including mercaptopurine for childhood acute lymphoblastic leukemia (ALL) treatment is an amazing success story, with cure or long-term remission rates now being greater than 90%. Although the metabolism of thiopurines is well known (Krynetski and Evans, 2003) , surprisingly little is understood about the mechanism by which thiopurines induce DNA damage and kill cancer cells. When thiopurines are metabolized into active nucleotide forms, the predominant mechanism of action is incorporation into DNA (Karran, 2006) . During replication, the thiopurine 6-thioguanine (6TG) causes base mispairing, which is then recognized by DNA mismatch repair (MMR) proteins. As part of a poorly understood process, the MMR machinery causes DNA strand breaks and invokes homologous recombination (HR) mediated repair. Inactivation or loss of MMR thus alleviates killing and chromosomal instability caused by thiopurines (Armstrong and Galloway, 1997; Buermeyer et al., 1999; Rajesh et al., 2011) .
RAD51D is one of the RAD51 family members indispensable for HR. RAD51D is now an established ovarian cancer susceptibility gene (Loveday et al., 2011; Thompson et al., 2013; Song et al., 2015) , and BRCA2-defective cancer cells are also sensitized to 6TG (Issaeva et al., 2010) . Indeed, a recent phase II clinical trial, NCT01432145, explored the use of a thiopurine in BRCA2-defective tumors; based upon genetic signatures, thiopurines might be used in other HR-defective cancers. At this time, there have been no reports of the successful generation of human knockout cells for any of the RAD51 paralogs. In fact, vertebrate cells deficient in any of the RAD51 paralogs have only been generated in mouse embryonic fibroblasts, DT40 avian cells, and Chinese hamster ovary cells (Lim and Hasty., 1996; Tsuzuki et al., 1996; Pittman and Schimenti, 2000; Takata et al., 2001; Deans et al., 2003; Hinz et al., 2006) . Even though RNA interference mediated knockdowns of several of the RAD51 family members in human cancer cells have been attempted, none achieved a substantially reduced expression (e.g., RAD51 by Wyatt and coworkers [Yang et al., 2008] ). In all cases examined, decreased expression of the RAD51 paralogs exhibited a similar sensitivity to DNA damaging agents and chromosome instability.
Our previous work established that RAD51D-dependent HR is protective downstream of MMR following 6TG treatment (Rajesh et al., 2011) . Specifically, Rad51d-deficient cells were extremely sensitive to 6TG, and there was a substantial increase in the frequency of chromosomal aberrations, particularly radials. There was also an increase in multinucleation and chromosomal aneuploidy in the Rad51d-deficient cells following 6TG treatment. The loss of MLH1 alleviated these phenotypes, demonstrating that the induced damage depends on functional MMR. The roles of RAD51D in genomic maintenance include telomere stability (Tarsounas et al., 2004) . In this regard, it is interesting to note that deoxy-thioguanine nucleotides can be incorporated into DNA by telomerase (Marathias et al., 1999; Tendian and Parker, 2000; Mender et al., 2015) . These observations prompted our investigation into three related topics. First, we sought to better understand the specific telomeric defect associated with Rad51d-deficient cells. Here, it was found that RAD51D is required for maintaining the telomeric 3 0 overhangs in mammalian cells. Second, we investigated telomeric DNA damage caused by 6TG. Chromosome fusions were induced by 6TG, some of which contained telomeric labeling. In Rad51d-deficient cells, there was increased co-localization of telomere probes with g-H2AX foci compared to Rad51d-proficient cells, which further increased upon treatment with 6TG. Lastly, we investigated via live cell imaging multi-nucleation induced by 6TG treatment of Rad51d-deficient cells. Note that different leukemias and lymphomas are also known to have increased aneuploidy and multinucleation, and telomere defects (Knecht et al., 2009; Knecht et al., 2010) . Time lapse video imaging following 6TG treatment demonstrated that Rad51d-deficient cells undergo primarily two forms of mitotic catastrophe, failed division and restitution, to form multinucleated cells. These findings provide a unique window into the formation of multinucleated Rad51d-deficient cells, and demonstrate that RAD51D provides a protective role against the telomeric DNA damage and chromosomal instability that thiopurine treatment causes.
MATERIALS AND METHODS

Cell Lines
Mice heterozygous for a mutation in the Mlh1 gene and mice heterozygous for null-alleles in Rad51d and Trp53 were crossed to generate murine embryonic fibroblasts (MEFs) with different combinations of the three mutated genes (Smiraldo et al., 2005; Rajesh et al., 2010; Rajesh et al., 2011) . Primary and immortalized mouse embryonic fibroblasts (MEFs) were grown in DMEM (Corning, Corning, NY) supplemented with 7.5% fetal bovine serum (Atlanta Biologicals, Flowery Branch, GA), 7.5% newborn calf serum (GE Life Sciences, Pittsburgh, PA), and antibiotics (GE) as previously described (Smiraldo et al., 2005) . The following immortalized cell lines used for these studies were Rad51d 
Electrophoresis and In-Gel Hybridization
Experiments were performed as described (Dionne and Wellinger, 1996; Hemann and Greider, 1999) . Telomere lengths were estimated from radioactive signals of alkali denatured gels hybridized with the end labeled (TTAGGG) 4 oligonucleotide, as described (Harley et al., 1990) . Relative G-strand overhang lengths were determined by the following equation, RSN/([TLC/TLE] 3 RSD), where RSN is the radioactive signal from native gels hybridized with the (CCCTAA) 4 oligonucleotide, TLC is the estimated telomere lengths of the control (homozygous wildtype) cells, TLE is the estimated telomere lengths, and RSD is the total radioactive signal from the denatured gels hybridized with the (TTAGGG) 4 oligonucleotide. Statistical significance of the experimental data was determined using SPSS MEFs were plated in a 6-well dish at a concentration of 6 x 10 4 cells per well and, after 24 h, treated with 50 or 100 nM 6TG (Sigma Environmental and Molecular Mutagenesis. DOI 10.1002/em RAD51D Protects Against 6TG Damage and ToxicityAldrich, St. Louis, MO) for 48 and 72 h. Following treatment, cells were trypsinized and proteins extracted in 13 cell lysis buffer (20 mM Tris, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM PMSF, 1% Triton X-100) containing protease inhibitor cocktail (Thermo Fisher, Waltham, MA) . Thirty micrograms of whole-cell protein extracts were separated using a 4-20% gradient gel (Bio-Rad, Hercules, CA). Western blot analysis was performed using rabbit polyclonal anti-g-H2AX (A300-081, Bethyl, Montgomery, TX) or rabbit monoclonal anti-GAPDH (D16H11, Cell Signaling, Danvers, MA). Primary incubations were followed with species specific IR Dye 800CW secondary antibody (Licor, Lincoln, NE), and signal detection was performed using a Licor Odyssey Sa Imaging System. Quantitative analysis of band intensity was performed using Image Studio software (LiCor, version 4.0, Lincoln, NE).
Immunofluorescence, Telomere Staining, and Chromosome Fusions
For the detection of g-H2AX foci and telomere co-localization, subconfluent cells, grown on sterile glass microscope slides or cover slips (VWR, Radnor, PA), were treated for the indicated times with 6TG. Following treatment, cells were fixed in 4% paraformaldehyde (Affymetrix, Santa Clara, CA), permeabilized with a 0.2% Triton X-100 solution, and incubated in block solution (5% dry milk in 13 PBS) at room temperature. This was followed by incubation with the anti-phospho-Histone H2AX (Ser139) mouse monoclonal antibody (1:600; Bethyl) and Oregon Green 488 goat anti-mouse IgG secondary (1:1,000; Molecular Probes (Thermo Fisher), Waltham, MA). Telomeres were visualized with the peptide nucleic acid probe Cy3-(CCCTAA) 3 (PNA Bio, Thousand Oaks, CA) and chromatin visualized by DAPI (Sigma).
For studies using primary MEFs to detect g-H2AX foci, cells containing 5 distinct g-H2AX foci were defined as foci-positive, and the percentage of g-H2AX foci at telomeres was calculated as ([number of g-H2AX foci at telomeres]/[number of g-H2AX foci]) 3 100% for each cell. Statistical significance was determined by comparing the mean number of g-H2AX foci at telomeres per cell for each genotype by ANOVA. Follow-up comparisons were performed using the Tukey HSD post hoc test.
For studies using immortalized MEFs and 6TG-induced damage, cells containing 10 distinct g-H2AX foci were defined as foci-positive, and the percentage of g-H2AX positive cells was calculated as ([number of g-H2AX positive cells]/[total number of cells]) 3 100. An EvosFL fluorescence microscope (Life Technologies, Carlsbad, CA) under a 603 oil objective was used to detect g-H2AX foci. Individual cells were manually scored through depth-of-field for foci, identified based upon signal intensity above general background staining levels and present within the nucleus as assessed by DAPI staining.
Metaphase chromosome spreads were prepared as described previously (Smiraldo et al., 2005) . The percent of fusions per chromosome was calculated as ([number of fusions]/[number of chromosomes]) 3 100 per metaphase spread. Statistical significance of the experimental data was determined by calculating a z-score. The presence of a telomere at a fusion was scored positive, and the percent telomere associated fusions was calculated as ([number of telomere positive fusions]/ [number of fusions]) 3 100.
For detection of telomeres at chromosome fusions, an Axiovert 200 with Axiovision (Zeiss, Oberkochen, Germany) fluorescence microscope and 1003 oil objective was used. For detection of g-H2AX foci at telomeres, cells were treated as described above and the telomere (CCCTAA) 3 probe added after g-H2AX antibody incubation. Individual cells were scored for co-localized foci by manual scanning through the cellular depth. Cells were scored positive when overlapping signals were observed within the nucleus. The number of g-H2AX foci co-localized with telomere signal was counted per nuclei and grouped into three categories: 0-2 co-localized foci, 3-7 co-localized foci, or 8 co-localized foci. A minimum of 200 nuclei were counted for each genotype and treatment.
Live Cell Imaging and Scoring Criteria
Rad51d
2/2 cells were plated onto 35 mm glass-bottom plates (Warner Instruments, CT) at a concentration of 4 3 10 4 cells/dish. After 24 h, cells were treated with 0, 50, or 100 nM 6TG and immediately transferred to a live-cell chamber maintained at 378C and 5% CO 2 . Grid areas selected for observation were sub-confluent, typically containing three to six individual cells in each grid, and images were captured over a minimum 72 h period at 403 magnification (DIC) (Leica Microsystems ASMDW). Nine adjacent grid areas were selected for observation, and images were captured every three minutes using a Photometrics Coolsnap HQ camera and combined into single video files using Fiji (ImageJ) software. Time in mitosis was calculated for cells from the beginning of observed rounding up until the same cell or daughter cells re-attached on the glass surface. Time in interphase was calculated as the period of time between observed mitotic events. Interphase times were not calculated for cells that did not attempt at least one mitotic division during the observation period. The mean and standard deviations were calculated using a one-tailed T-test (P < 0.05). Mitotic outcomes were scored as cell division, apoptosis, restitution, failed division, and mitotic arrest based upon the following criteria (Broude et al., 2008) . Division events were scored as cells that completed cytokinesis and formed two distinct, mono-nuclear daughter cells. Apoptotic events were scored as cells that rounded up, formed blebbed subcellular structures and were no longer distinguishable. Restitution and failed division were scored as cellular outcomes that led to the formation of multinucleated cells during the observation period. Restitution was defined as the inability of a cell to complete cytokinesis despite the initial appearance of two daughter cells that began reattaching to the plate and subsequently fusing into a single large multinucleated cell. Failed division was defined as an event in which the cell rounded up, but there was no observable attempt at cytokinesis and the cell reattached to the glass surface. An arrest event was defined as a cell observed to undergo one successful division but subsequently did not attempt another cell division during the experiment.
RESULTS
RAD51D Is Required to Maintain Telomeric 3 0 Overhangs
Prior work from Pittman and colleagues demonstrated that Rad51d is essential for maintaining both chromosome and telomere stability (Smiraldo et al., 2005) . However, the precise function of RAD51D at the telomere remains unresolved. Because Rad51d is an essential gene, a Trp53 (p53)-deficient background was necessary to restore cell viability in order to perform the experiments as described in this manuscript in both primary and immortalized MEFs. For these experiments, we utilized two different sets of primary MEFs including Rad51d 1/1 Trp53 the telomere for all genotypes (Fig. 1A) . Pretreatment with the single-strand-specific mung bean nuclease caused loss of signals (data not shown), demonstrating that the probe was bound to single-stranded, telomeric 3 0 overhangs. Note that Rad51d-deficient cells have a high level of hypo-and hyperploidy (Smiraldo et al., 2005) , which prevented a direct comparison of signal intensity among genotypes. The DNA was next alkali denatured and hybridized with a (TTAGGG) 4 probe (Fig. 1B) . Differences of telomere lengths among samples were taken into consideration when calculating the relative length of the telomeric 3 0 overhangs (Fig. 1C) . No significant difference in the relative length of the telomeric overhangs was observed when comparing homozygous wild-type, Rad51d P 5 0.001, Rad51d 2/2 Trp53 2/2 vs. Trp53 2/2 P 0.001). We next determined whether spontaneous damage was evident at telomeres as measured by phosphorylated histone H2AX (ser139, g-H2AX) in primary MEFs. When comparing the percentage of g-H2AX foci that localized to telomeres, no significant difference was observed between homozygous wild-type and Trp53 2/2 MEFs (P 5 0.929) (not shown). However, a twofold increase in the telomeric localization of g-H2AX foci was observed in the Rad51d
2/2
Trp53
2/2 MEFs compared to the controls (Fig. 1D ,E, wildtype vs. Rad51d 2/2 Trp53 2/2 P 5 0.011; Trp53 2/2 vs. Rad51d 2/2 Trp53 2/2 P 5 0.002), suggesting that some telomeres are recognized as DSBs in the absence of RAD51D.
Collectively, these results demonstrate that RAD51D Telomere lengths were estimated as described [Harley et al 1990] .
Error bars are the SEM from at least three independent experiments. (D) Localization of g-H2AX foci at telomeres in primary MEFs. Telomeric DNA was identified by the peptide nucleic acid (PNA) probe (red), g-H2AX was immunolabeled by indirect immunofluorescence (green), and DNA stained with DAPI (blue). White arrowheads demonstrate the localization of g-H2AX foci at telomeres. (E) Percentage of g-H2AX foci at telomeres in primary wild-type MEFs (n 5 58 nuclei scored) and primary Rad51d 2/2 MEFs (n 5 59 nuclei scored). Statistical significance was calculated by ANOVA; *indicated P 5 0.011.
Environmental and Molecular Mutagenesis. DOI 10.1002/em RAD51D Protects Against 6TG Damage and Toxicitycontributes to maintaining telomeric 3 0 overhangs in mammalian cells.
H2AX Phosphorylation in Response to 6TG Treatment
Induction of g-H2AX following 6TG treatment was assessed by Western blotting and immunofluorescence in immortalized Rad51d-proficient and Rad51d-deficient MEFs, both in a Trp53-deficient background. Following treatment with 50 nM 6TG, an increase of g-H2AX at 48 and 72 h in the Rad51d-proficient cells and in the Rad51d-deficient cells was observed ( Fig. 2A) . At this dose and time point of 48 h, quantitation revealed that g-H2AX was not statistically different in Rad51d-proficient and Rad51d-deficient cells (Fig. 2B , grey bars, 2.5-fold). At a 50 nM dose for 72 h, g-H2AX was higher in Rad51d-proficient cells (Fig. 2B, black bars, 4 .5-fold compared to 2.5-fold in Rad51d-deficient cells). Treatment with 100 nM 6TG at 48 and 72 h induced g-H2AX to a greater extent than that seen with 50 nM 6TG in all genotypes. No statistically significant differences were seen between Rad51d-proficient and Rad51d-deficient cells (Fig. 2C) . Our prior work established that in the absence of MLH1, Rad51d-deficient cells were less sensitive to killing and chromosomal instability caused by 6TG (Rajesh et al., 2011 
Mlh1
2/2 cells at 50 nM 6TG at either time point (Fig. 2B) . At 100 nM 6TG, there was a modest induction of g-H2AX at 100 nM 6TG that was lower compared to MLH1-proficient cells regardless of RAD51D status (Fig. 2C ). This is consistent with prior observations and further supports idea that the specificity of the clastogenic damage caused by 6TG in the absence of RAD51D depends on functional MMR. Using immunofluorescence microscopy, nuclei with ten or more g-H2AX foci after 72 h 6TG treatment were scored as positive. The untreated Rad51d-deficient cells had a basal level of 15% g-H2AX foci, whereas no g-H2AX positive Rad51d-proficient cells were observed (Fig. 2D, white bars) , indicative of the extensive genome instability associated with Rad51d deficiency. Following treatment with 50 nM 6TG, g-H2AX foci positive cells increased to 42% in Rad51d-proficient cells, whereas in Rad51d-deficient cells the g-H2AX foci positivity went from a basal level of 15% to 27% (Fig. 2D, grey bars) . This agreed with muted induction of H2AX by 6TG in the absence of RAD51D as observed by Western blotting in Figure 2B . At the higher dose of 100 nM 6TG, the increase in g-H2AX foci positive cells was similar in both genotypes following treatment with 100 nM 6TG (Fig. 2D, black bars) . In examining the Rad51d 2/2 Mlh1 2/2 cells for g-H2AX foci, the results were entirely consistent with the observations by Western blotting for g-H2AX in Figure 2A ,B. Specifically, Figure 2C shows that there Environmental and Molecular Mutagenesis. DOI 10.1002/em was no g-H2AX foci induction above basal levels at 50 nM 6TG, whereas at the higher dose of 100 nM, a statistically significant but lessened induction of foci was observed in Rad51d 2/2 Mlh1 2/2 cells compared to the Mlh1 1/1 cells.
c^H2AX and Telomere Co-Localization in Response to 6TG Treatment
To determine whether g-H2AX foci were associated with telomeres in response to 6TG, immortalized MEFs containing 10 g-H2AX foci were scored after 6TG treatment (Fig. 3A) . Co-localization of the telomere probe with g-H2AX foci was grouped into three categories (0-2, 3-7, and 8 foci/nuclei, Fig. 3B ). In vehicle treated, a majority (80%) of Rad51d-proficient cells contained between zero and two co-localized foci per nucleus (Fig.  3B , left panel, white portion of bar). In contrast, the majority (>60%) of vehicle-treated Rad51d-deficient cells contained three or more co-localized foci per nucleus (Fig. 3B, middle panel, grey portion) indicative of an elevated basal level of DNA damage in the absence of RAD51D. In response to 50 nM 6TG treatment, there was an induction of co-localized foci per nucleus in Rad51d-proficient cells (Fig. 3B, left panel) . In Rad51d-deficient cells, 50 nM 6TG treatment caused a large increase in the number of cells with 81 co-localized foci (Fig. 3B, middle panel, black portion) . The higher dose of 100 nM induced an equivalent co-localization in Rad51d-proficient and Rad51d-deficient cells (Fig. 3B , left versus middle panel). These data demonstrate that 6TG induced DNA damage as visualized by g-H2AX at telomeres in a dose-dependent manner, and at least at the lower dose of 6TG, there is more telomeric damage in the absence of RAD51D. Figure 3B (right panel) also shows that g-H2AX localization at telomeres is reduced in the absence of MLH1, which is consistent with prior work showing that MMR recognition of 6TG damage promotes clastogenic events.
Previously, we reported a striking induction of radial chromosomes in Rad51d-deficient cells following 6TG treatment (Rajesh et al., 2011) . To determine whether chromosome fusions were associated with telomere ends, telomere associated fusions were examined in metaphase Localization of g-H2AX foci co-localized with telomere signal at telomeres in immortalized MEFs after treatment with vehicle alone, 50 nM, or 100 nM 6TG. The three categories are 0-2 co-localized foci ( w ), 3-7 co-localized foci (), or 8 co-localized foci () per nuclei.
spreads. As expected, no fusions were detected in vehicle treated Rad51d-proficient cells (Table I ; n 5 1,005 scored). After treatment with 50 or 100 nM 6TG, the number of fusions observed in Rad51d-proficient cells was detectable but, as expected, remained low, 0.4 and 0.8%, respectively (Fig. 4, white bars) . Too few fusions were observed to clearly determine telomere association (Table I ). In the vehicle-treated Rad51d-deficient cells, a basal level of 1.1% chromosome fusions was detected, which increased to 2.7 and 6.9% following treatment with 50 and 100 nM 6TG, respectively (Fig. 4 , grey bars, P < 0.05). In vehicle-treated Rad51d-deficient cells, telomere-associated fusions were detectable and do appear to increase following 6TG treatment, but the level of fusions regardless of telomere association was too few to make any statistically meaningful conclusions (Table I ). Lastly, a basal level of 0.6% chromosome fusions was detected in the Rad51d
Mlh1
2/2 cells, which increased by a statistically insignificant amount to 0.9% and 1.6% following treatment with 50 and 100 nM 6TG, respectively (Fig. 4, black bars) . The data showing that 6TG-induced fusions was reduced in Mlh1-deficient cells agreed with prior data from us and others that the cytogenetic damage caused by 6TG is dependent at least in part on functional MMR (Armstrong and Galloway, 1997; Rajesh et al., 2011) .
6-Thioguanine Induces Mitotic Catastrophe in Rad51d-Deficient Cells
Our prior work demonstrated that treatment with 100 nM 6TG induced aneuploidy and multinucleation in Rad51d-deficient cells (Rajesh et al., 2011) . Here, the induction of multinucleated cells was verified following treatment with a lower dose of 50 nM 6TG (Supporting Information Fig. 1 ). Note also we investigated whether there was an unequal distribution of telomeric DNA in the multinucleated cells because of such observations in a prior report (Knecht et al., 2009 ). However, we show in Supporting Information Figure 2 that the multinucleated cells contained an equal distribution of telomeric DNA in this experimental system.
To investigate the origins of the multinucleated phenotype after 6TG exposure, time lapse video imaging was used to monitor mitotic events over the course of at least 72 h of drug exposure. Rad51d-deficient cells treated with 50 nM 6TG had an increased time in interphase by 16 h (from 24 to 40 h) compared with untreated cells (Fig. 5A , P 5 3.31 3 10 26 ). Rad51d-deficient MEFs treated with 100 nM 6TG showed an increased time in interphase by 9 h (from 24 to 33 h) compared to untreated cells ( Fig.  5A, P 5 2.98 3 10 
27
). Rad51d-deficient cells treated with 50 nM 6TG also spent twice as much time completing mitosis compared to untreated cells (P 5 0.035), whereas cells treated with 100 nM 6TG spent a similar time in mitosis as the untreated cells (P 5 0.237) (Fig.  5B) . The number of apoptotic, restitution, and failed division events were substantially increased in Rad51d-deficient cells treated with 50 nM 6TG (Fig. 5C, grey bars) , whereas a greater percentage of cells treated with 100 nM 6TG (black bars) had an increased number of arrested cells. These observations at the higher dose are consistent with the dose-dependent G2 arrest previously observed (Rajesh et al., 2011 ). An example of a failed division following treatment with 50 nM 6TG is shown in Figure 5D and as Supporting Information Video 1. In the center of the field, a cell is observed to round up at the start of (1) 0.34 (11) 1 (10) a Frequency of end-to-end fusions represented as the proportion of the total number of chromosomes scored for that sample. The total number is shown in parentheses. b 1TTAGGG and 2TTAGGG refer to the presence or absence of telomeric repeats at the fusion point. The proportion (total number) of endto-end fusions with or without telomeric signal is shown. Fig. 4 . 6TG induced chromosome fusions in Rad51d-deficient immortalized MEFs. After treatment for 72 h chromosomes were stained with DAPI. The number of chromosome fusions was scored as a percent of the total number of chromosomes in vehicle, 50 nM, or 100 nM 6TG-treated Rad51d 1/1 ( w ), and Rad51d 2/2 () and Rad51d
MEFs (). Statistical significance was determined by calculating a zscore; * indicates P < 0.05.
Environmental and Molecular Mutagenesis. DOI 10.1002/em mitosis (time-stamp 69:39) and attempt to divide for greater than 2 h, before re-attaching to the glass surface as a single multinucleated cell (time-stamp 73:48) . An example of a restitution event observed following treatment with 50 nM 6TG is shown in Figure 5E and as Supporting Information Video 2. The cell is observed to round up (time-stamp 33:09) and divide into what appears to be three daughter cells (35:39). The daughter cells fail to complete cytokinesis, and fuse into a single multinucleated cell (37:06).
DISCUSSION
Thiopurines induce a G2 arrest, which presumably prevents cells with damaged DNA from entering what would otherwise become an abnormal mitosis (Armstrong and Galloway, 1997; Buermeyer et al., 1999; Rajesh et al., 2011) . However, co-treatment with caffeine or UCN-01 to block ATM/ATR signaling can override the G2 arrest, from which cells subsequently enter tetraploid G1 arrest (Yan et al., 2004) . In Rad51d-deficient cells, the G2 arrest caused by 6TG was heightened but transient; by 72 h, both Rad51d-deficient and Rad51d-proficient cells progressed into mitosis, as demonstrated by flow cytometry and phospho-histone H3 staining (Rajesh et al., 2011) . One implication is that release from this G2 checkpoint does not require the resolution/completion of HR, and as such might help explain how cancer cells achieve aneuploidy. 6TG treatment induced aneuploidy and multinucleated cells (Rajesh et al., 2011) . Similar to this Rad51d-deficient cellular phenotype, different leukemia and lymphomas are known to have increased aneuploidy and multinucleation. One notable example is ReedSternberg (RS) cells associated with the pathology of Hodgkin's lymphoma (Mauch et al., 2006) . The data presented here demonstrates that multinucleation following 6TG treatment occurs via mitotic catastrophe in two ways: failed division and restitution. In this system, mitotic catastrophe resulted in multinucleated cells that do not undergo apoptosis over the duration of the observations here. When treated with the 50 nM 6TG dose, a larger percentage of multinucleated Rad51d-deficient cells undergo mitotic catastrophe, which was not observed in cells at the 100 nM dose presumably because of the heightened arrest. These results suggest that a percentage In fact, multinucleation and mitotic catastrophe is proposed to be a favored cell death mechanism after cell cycle arrest (Castedo et al., 2004; Fragkos and Beard, 2011) .
Phosphorylation of Serine-139 on H2AX was measured as a marker of DNA damage, and 6TG induced g-H2AX as measured by Western blotting and immunofluorescence in both Rad51d-deficient and Rad51d-proficient cells. It was interesting to note that, as detected by Western blotting and immunofluorescence, g-H2AX induction seemed muted in the Rad51d-deficient cells at the lower dose of 50 nM. It is tempting to speculate that the absence of RAD51D disrupts not just HR repair but also associated DNA damage signaling. In fact, a role for the paralog RAD51C in checkpoint signaling was demonstrated (Badie et al., 2009 ). However, note that g-H2AX induction is a highly dynamic process intertwined with yet to be clarified connections with the induction of apoptosis and a broader epigenetic reprogramming in cancer (Lu et al., 2006; Cook et al., 2009; Xiao et al., 2009; Monteiro et al., 2014; Liu et al., 2016) .
RAD51D, a protein required for HR, was demonstrated previously to have a role in telomere protection (Tarsounas et al., 2004) . Loss of RAD51D conferred extensive chromosome instability, increased chromosome fusions, and accelerated telomere attrition (Tarsounas et al., 2004; Smiraldo et al., 2005) . To further examine the role of RAD51D at telomeres, we analyzed the length of the 3 0 telomeric overhanging tail in Rad51d-deficient MEFs. Rad51d-deficient cells had an approximately 40% increase in overhang signal intensity. These data demonstrate that loss of RAD51D affects the length of the 3 0 telomeric overhang, and suggest that RAD51D is required for the regulation of telomere termini. Telomere dysfunction is known to activate DNA damage responses, and loss of murine exonuclease 1 (Exo1) alleviated deleterious cellular responses in telomere dysfunctional mice (Schaetzlein et al., 2007) . This implies that damage disrupting the normal telomere protective mechanisms can expose chromosome ends to exonucleolytic processing that can promote chromosome fusions. Exo1 deletion also conferred cellular resistance to killing by 6TG (Schaetzlein et al., 2007) , which implicates telomeric damage as a mechanism of action for 6TG. Because mammalian telomeres contain a G 3 repeat in its canonical sequence, 6TG (as the deoxynucleoside triphosphate) can become incorporated into telomeric DNA by telomerase (Marathias et al., 1999; Tendian and Parker, 2000) . It was more recently reported that the deoxynucleoside of 6TG can directly damage telomeric DNA, and that hTERT positive cells are sensitized to this treatment (Mender et al., 2015) . We measured the distribution of telomeres in the multinucleated Rad51d-deficient cells because prior reports have shown structural telomeric defects and unequal distribution in multinucleated Reed-Sternberg cells (Knecht et al., 2009; Knecht et al., 2010) . However, no unequal telomere distribution was observed in the Rad51d-deficient MEFs after 6TG treatment. Collectively, this work contributes to the understanding of 6TG-induced telomere damage and the negative consequences for chromosomal instability in the absence of RAD51D-dependent processes at telomeres.
RAD51D is a RAD51 family member broadly appreciated to be indispensable for HR; yet, the specialized functions of the individual protein products have evaded full elucidation. Components of HR are recruited to stalled replication forks and inter-strand crosslinks (ICLs), as well as DNA double strand breaks (DSBs). Recently, a dominant RAD51 mutation in a patient with Fanconi anemia-like phenotypes was characterized and uncovered a role for RAD51 in ICL repair independent of HR (Wang et al., 2015) , suggesting there is much more to learn about these highly related yet potentially separable processes. Human variant alleles of the RAD51 paralogs confer cancer susceptibility, for example, RAD51B mutations are associated with breast cancer (Golmard et al., 2013; Pelttari et al., 2016) , RAD51C mutations are associated with breast and ovarian cancer, and RAD51D mutations are associated with ovarian cancer (Meindl et al., 2010; Vaz et al., 2010; Coulet et al., 2013; Song et al., 2015) . There are many more mutations of unknown significance in these paralogs. Our results suggest that clinical variability in how patients respond to thiopurine treatment, as well as their potential risk for a future, therapy-related secondary dysplasia might include the status of RAD51D-dependent processing of telomeres.
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